Page last updated: 2024-11-06

6-nitrobenzo(a)pyrene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID44374
CHEMBL ID16374
CHEBI ID82503
SCHEMBL ID819463
MeSH IDM0106773

Synonyms (28)

Synonym
6-nitrobenzo(a)pyrene
benzo(a)pyrene, 6-nitro-
ccris 2434
6-nitrobenz(a)pyrene
brn 2472924
6-nitro-benzo[def]chrysene
CHEMBL16374
chebi:82503 ,
6-nitrobenzo[a]pyrene
63041-90-7
C19472
FT-0640865
unii-u2bfp66yg1
u2bfp66yg1 ,
hsdb 8186
benzo[a]pyrene, 6-nitro-
SCHEMBL819463
6-nitrobenzo[def]chrysene #
NMMAFYSZGOFZCM-UHFFFAOYSA-N
DTXSID4075083
6-nitrobenzo[a]pyrene, bcr(r) certified reference material
benzo[a]pyrene, 6-nitro-; 6-nitrobenzo[a]pyrene
Q27156008
6-nitrobenzo(a)pyrene [iarc]
nitrobenzo(a)pyrene, 6-
6-nitrobenzo[pqr]tetraphene
6-nitrobenz[a]pyrene
8-nitropentacyclo[10.6.2.0?,?.0?,??.0??,??]icosa-1(18),2(7),3,5,8,10,12,14,16,19-decaene
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
ortho- and peri-fused polycyclic arene
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (14)

Assay IDTitleYearJournalArticle
AID93183Mutagenic activity for hypoxanthine-guanine phosphoribosyltransferase (HGPRT) in chinese hamster ovary cells at a dose of 0 ug/ml; Exp II1984Journal of medicinal chemistry, Sep, Volume: 27, Issue:9
Synthesis, spectral analysis, and mutagenicity of 1-, 3-, and 6-nitrobenzo[a]pyrene.
AID93184Mutagenic activity for hypoxanthine-guanine phosphoribosyltransferase (HGPRT) in chinese hamster ovary cells at a dose of 0 ug/ml; Exp III1984Journal of medicinal chemistry, Sep, Volume: 27, Issue:9
Synthesis, spectral analysis, and mutagenicity of 1-, 3-, and 6-nitrobenzo[a]pyrene.
AID93186Mutagenic activity for hypoxanthine-guanine phosphoribosyltransferase (HGPRT) in chinese hamster ovary cells at a dose of 1 ug/ml; Exp II1984Journal of medicinal chemistry, Sep, Volume: 27, Issue:9
Synthesis, spectral analysis, and mutagenicity of 1-, 3-, and 6-nitrobenzo[a]pyrene.
AID93188Mutagenic activity for hypoxanthine-guanine phosphoribosyltransferase (HGPRT) in chinese hamster ovary cells at a dose of 3 ug/ml; Exp I1984Journal of medicinal chemistry, Sep, Volume: 27, Issue:9
Synthesis, spectral analysis, and mutagenicity of 1-, 3-, and 6-nitrobenzo[a]pyrene.
AID93182Mutagenic activity for hypoxanthine-guanine phosphoribosyltransferase (HGPRT) in chinese hamster ovary cells at a dose of 0 ug/ml; Exp I1984Journal of medicinal chemistry, Sep, Volume: 27, Issue:9
Synthesis, spectral analysis, and mutagenicity of 1-, 3-, and 6-nitrobenzo[a]pyrene.
AID93192Mutagenic activity for hypoxanthine-guanine phosphoribosyltransferase (HGPRT) in chinese hamster ovary cells at a dose of 6 ug/ml; Exp II; No data1984Journal of medicinal chemistry, Sep, Volume: 27, Issue:9
Synthesis, spectral analysis, and mutagenicity of 1-, 3-, and 6-nitrobenzo[a]pyrene.
AID93185Mutagenic activity for hypoxanthine-guanine phosphoribosyltransferase (HGPRT) in chinese hamster ovary cells at a dose of 1 ug/ml; Exp I; No data1984Journal of medicinal chemistry, Sep, Volume: 27, Issue:9
Synthesis, spectral analysis, and mutagenicity of 1-, 3-, and 6-nitrobenzo[a]pyrene.
AID93193Mutagenic activity for hypoxanthine-guanine phosphoribosyltransferase (HGPRT) in chinese hamster ovary cells at a dose of 6 ug/ml; Exp III1984Journal of medicinal chemistry, Sep, Volume: 27, Issue:9
Synthesis, spectral analysis, and mutagenicity of 1-, 3-, and 6-nitrobenzo[a]pyrene.
AID93191Mutagenic activity for hypoxanthine-guanine phosphoribosyltransferase (HGPRT) in chinese hamster ovary cells at a dose of 6 ug/ml; Exp I1984Journal of medicinal chemistry, Sep, Volume: 27, Issue:9
Synthesis, spectral analysis, and mutagenicity of 1-, 3-, and 6-nitrobenzo[a]pyrene.
AID200690Mutagenic activity in an Ames test on Salmonella Typhimurium TA98; Activity is log of revertants/nmol1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity.
AID23442Partition coefficient (logP)1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity.
AID93189Mutagenic activity for hypoxanthine-guanine phosphoribosyltransferase (HGPRT) in chinese hamster ovary cells at a dose of 3 ug/ml; Exp II1984Journal of medicinal chemistry, Sep, Volume: 27, Issue:9
Synthesis, spectral analysis, and mutagenicity of 1-, 3-, and 6-nitrobenzo[a]pyrene.
AID93190Mutagenic activity for hypoxanthine-guanine phosphoribosyltransferase (HGPRT) in chinese hamster ovary cells at a dose of 3 ug/ml; Exp III1984Journal of medicinal chemistry, Sep, Volume: 27, Issue:9
Synthesis, spectral analysis, and mutagenicity of 1-, 3-, and 6-nitrobenzo[a]pyrene.
AID93187Mutagenic activity for hypoxanthine-guanine phosphoribosyltransferase (HGPRT) in chinese hamster ovary cells at a dose of 1 ug/ml; Exp III; No data1984Journal of medicinal chemistry, Sep, Volume: 27, Issue:9
Synthesis, spectral analysis, and mutagenicity of 1-, 3-, and 6-nitrobenzo[a]pyrene.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (33)

TimeframeStudies, This Drug (%)All Drugs %
pre-199028 (84.85)18.7374
1990's3 (9.09)18.2507
2000's2 (6.06)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.44

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.44 (24.57)
Research Supply Index3.64 (2.92)
Research Growth Index4.08 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.44)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (5.41%)6.00%
Case Studies1 (2.70%)4.05%
Observational0 (0.00%)0.25%
Other34 (91.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]